Feds Nail Brooklyn Pill Boss In Multi-Million Medicare Scam

Federal prosecutors say Brooklyn pharmacy owner Taesung Kim has finally been held to account after years of allegations that his pharmacies billed Medicare and Medicaid for medications that were unnecessary or never dispensed and paid kickbacks to patients and prescribers. U.S. Attorney Joseph Nocella Jr. branded the conduct “despicable” and said it preyed on vulnerable beneficiaries, describing the outcome as a major step in a long-running probe into public health care dollars gone wrong.

In a post on X on April 24, the U.S. Attorney's Office, EDNY announced that “Today, Taesung Kim was held accountable for the despicable crime of defrauding Medicare and Medicaid.” Prosecutors said the development follows work that began when an indictment was unsealed in 2023, capping years of investigative legwork that moved from quiet document review to public courtroom drama.

Background and charges

The case traces back to an indictment unsealed in Brooklyn in May 2023 that accused Kim and a co-owner of submitting false claims, paying kickbacks and laundering proceeds, according to a U.S. Department of Justice press release. The Justice Department said the pharmacies submitted roughly $26 to $29 million in fraudulent claims between 2015 and 2022. Prosecutors alleged that sham companies and layered transfers helped conceal the source and movement of the money.

The indictment and related filings say employees were instructed to "offer illegal kickbacks and bribes in the form of supermarket gift certificates" and to bill for over-the-counter items that were never actually dispensed. Court documents, as summarized by the Justice Department, describe investigators tracing payments and transfers that allegedly funded the kickbacks. Prosecutors say those incentives drove prescriptions and refills that in turn generated the fraudulent billing.

How prosecutors say the scheme worked

Local reporting and the federal indictment name Elmcare Pharmacy and NY Elm Pharmacy in Flushing and 888 Pharmacy and Huikang Pharmacy in Brooklyn as part of the pharmacy network prosecutors targeted. QNS covered the arraignments and detailed the alleged cash movements that investigators say were used to bankroll kickbacks. Residents in those neighborhoods told reporters they were stunned when federal agents appeared with arrest warrants and started seizing records from storefront pharmacies that had long blended into the block.

Legal consequences

The original indictment charged Kim and his co-defendant with conspiracy to commit health care fraud, conspiracy to commit money laundering and conspiracy to pay illegal health care kickbacks and bribes, all felonies that carry potentially lengthy prison terms if convictions follow. Legal analysts at McGuireWoods noted that defendants in such cases can also face civil liability under the False Claims Act, which allows the government to seek multiple times the alleged loss. That means any criminal penalties and forfeiture could be stacked on top of civil recoveries if the allegations are proved.

Part of a wider enforcement push

Federal officials say Kim's case is one piece of a broader crackdown on pharmacy and adult-day-care fraud that has yielded a string of high-dollar arrests and indictments across New York. IRS Criminal Investigation has highlighted similar multi-agency operations involving pharmacies and related providers, while the SSA Office of the Inspector General has reported that national strike forces have gone after hundreds of defendants in schemes tied to alleged losses that run into the billions.

What's next

Prosecutors say their X post reflects the latest procedural milestone in Kim's case, with the formal outcome and any sentencing or restitution orders to be detailed in court dockets and written judgments. Defense statements were not included in the public announcement, and federal charging papers continue to stress that an indictment is only an allegation, not proof of guilt. For now, the matter remains on the Eastern District of New York's health care fraud docket, where future filings will spell out the final consequences for the Brooklyn pharmacy owner at the center of the case.